Effest of Molsidomine on t-PA and PAI Activity in Man: A Double Blind, Placebo Controlled Study

Thromb Haemost 1990; 64(03): 485
DOI: 10.1055/s-0038-1647341

Letter to the Editor

Schattauer GmbH Stuttgart

Authors

Lilia Grodzinska

^*Copernikus Medical Academy 31-531 Krakow, Poland
Gerd Hafner

II. Medizinische Klinik Johannes- Gutenberg-Universitat 6500 Mainz 1, FR Germany
Harald Darius

II. Medizinische Klinik Johannes- Gutenberg-Universitat 6500 Mainz 1, FR Germany
II Medizinische Klinik

II. Medizinische Klinik Johannes- Gutenberg-Universitat 6500 Mainz 1, FR Germany

References
1 Feelisch M, Noack EA. Correlation between nitric oxide formation during degradation of organic nitrates and activation of guanylate cyclase. Eur J Pharmacol 1987; 139: 19-30
2 Darius H, Ahland B, Rücker W, Klaus W, Peskar BA, Schror K. The effects of molsidomine and its metabolite SIN-I on coronary vessel tone, platelet aggregation, and eicosanoid formation in vitro - inhibition of 12-HPETE biosynthesis. J Cardiovasc Pharmacol 1985; 6: 115-121
3 Grodzinska L, Basista M, Swies J. Molsidomine and its metabolite SIN-I. Fibrinolytic and disaggregating properties. In: Prostaglandins and Other Eicosanoids in the Cardiovascular System Schror K. (ed). Karger, Basel: 1985: 509-512
4 Klocking HP, Hoffmann A, Markwardt F. Release of plasminogen activator by molsidomine and its active metabolite SIN-I. Pharmazie 1987; 42: 354